Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 28 Issue 12, December 2021

Cover Credit:Suprachoroidal injection provides a new, noninvasive route of delivery for ocular gene therapy. Two weeks after suprachoroidal injection of 7.8x109 genome copies of AAV2tYF-GRK1-GFP in Brown Norway rats, an ocular section shows strong GFP fluorescence (green) and immunostaining for GFP (red) in photoreceptor cell bodies (outer nuclear layer, ONL), inner segments (IS) and outer segments (OS). GRK1 is the photoreceptor-specific rhodopsin kinase promoter.

Volume 28 Issue 12

Subscribe

Review Article

Top of page ⤴

Article

Top of page ⤴

Correction

Top of page ⤴

Search

Advanced search

Quick links